标题
Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 15, Issue -, Pages 2445-2456
出版商
Informa UK Limited
发表日期
2021-06-09
DOI
10.2147/dddt.s308377
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis
- (2020) Dandan Zhao et al. Cancer Cell International
- Periostin Promotes Colorectal Tumorigenesis through Integrin-FAK-Src Pathway-Mediated YAP/TAZ Activation
- (2020) Handong Ma et al. Cell Reports
- MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway
- (2020) Li-wen Yao et al. Oncogenesis
- Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling
- (2020) Qing Liu et al. OncoTargets and Therapy
- Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation
- (2020) Qi Wang et al. Cancer Medicine
- Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer
- (2020) Yang Tang et al. CANCER CELL
- Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance
- (2020) Tomoyuki Uchihara et al. CANCER RESEARCH
- Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
- (2020) Jo Waaler et al. Communications Biology
- Anti-proliferative and anti-migratory effects of a novel YAP-TEAD interaction inhibitor identified using in silico molecular docking
- (2019) Sarah Smith et al. JOURNAL OF MEDICINAL CHEMISTRY
- FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway
- (2019) Yeo et al. Cancers
- The Hippo Signaling Pathway in Development and Disease
- (2019) Yonggang Zheng et al. DEVELOPMENTAL CELL
- EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance
- (2019) Changhao Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Verteporfin targeting YAP1/TAZ‐TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells
- (2019) Julie Giraud et al. INTERNATIONAL JOURNAL OF CANCER
- Down‐regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor
- (2019) Yangyang Yao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer
- (2019) Haisheng Zhang et al. Cancer Discovery
- Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells
- (2018) Ting Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
- (2018) Helena J. Janse van Rensburg et al. CANCER RESEARCH
- Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma
- (2018) Ping-Chih Hsu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Identification of Cdk1–LATS–Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells
- (2018) Benjamin Yeung et al. MOLECULAR CANCER RESEARCH
- Role of YAP in lung cancer resistance to cisplatin
- (2018) Juan Song et al. Oncology Letters
- YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
- (2018) Min Hwan Kim et al. Cancer Immunology Research
- Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
- (2018) et al. Cancers
- Matrix stiffness mediates stemness characteristics via activating the Yes-associated protein in colorectal cancer cells
- (2018) Fengbo Tan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells
- (2018) Bi‑Sheng Liu et al. ONCOLOGY REPORTS
- Loss of VGLL4 suppresses tumor PD‐L1 expression and immune evasion
- (2018) Ailing Wu et al. EMBO JOURNAL
- Panobinostat sensitizes KRAS-mutant non-small-cell lung cancer to gefitinib by targeting TAZ
- (2017) Wen-Ying Lee et al. INTERNATIONAL JOURNAL OF CANCER
- A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
- (2017) Shumei Song et al. MOLECULAR CANCER THERAPEUTICS
- Hippo pathway mediates resistance to cytotoxic drugs
- (2017) Taranjit S. Gujral et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
- (2017) Venkata Ramesh Dasari et al. Oncotarget
- YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
- (2017) Elena Ghiso et al. NEOPLASIA
- Expression and Yes-Associated Protein in Gastric Adenocarcinoma and Inhibitory Effects of its Knockdown on Gastric Cancer Cell Proliferation and Metastasis
- (2017) J. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling
- (2016) Hui Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice
- (2016) ZHOU ZHOU et al. Oncology Letters
- Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations
- (2016) Albino Troilo et al. Oncotarget
- YAP promotes erlotinib resistance in human non-small cell lung cancer cells
- (2016) Ping-Chih Hsu et al. Oncotarget
- Hippo Pathway Regulation of Gastrointestinal Tissues
- (2015) Fa-Xing Yu et al. Annual Review of Physiology
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer
- (2015) S. Song et al. CLINICAL CANCER RESEARCH
- Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors
- (2015) Chun-Han Lin et al. MOLECULAR BIOLOGY OF THE CELL
- A gp130–Src–YAP module links inflammation to epithelial regeneration
- (2015) Koji Taniguchi et al. NATURE
- Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
- (2015) Jung-Soon Mo et al. NATURE CELL BIOLOGY
- AMPK modulates Hippo pathway activity to regulate energy homeostasis
- (2015) Wenqi Wang et al. NATURE CELL BIOLOGY
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- RUNX3 is a novel negative regulator of oncogenic TEAD–YAP complex in gastric cancer
- (2015) Y Qiao et al. ONCOGENE
- Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy
- (2015) Ajaybabu V. Pobbati et al. STRUCTURE
- The effect of statins on cancer cells—review
- (2015) Lucyna Matusewicz et al. TUMOR BIOLOGY
- MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells
- (2015) Cristian Taccioli et al. Oncotarget
- Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
- (2015) Wenqi Wang et al. Cell Reports
- Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
- (2015) Yusuke Oku et al. FEBS Open Bio
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
- (2014) Y. Zhao et al. CANCER RESEARCH
- VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
- (2014) Wenjing Zhang et al. CELL RESEARCH
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition
- (2014) M. Diepenbruck et al. JOURNAL OF CELL SCIENCE
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration
- (2014) W Mi et al. ONCOGENE
- Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction
- (2014) Zhisen Zhang et al. ACS Medicinal Chemistry Letters
- Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein
- (2014) Michael DeRan et al. Cell Reports
- Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
- (2013) P. P. Singh et al. ANNALS OF ONCOLOGY
- Emerging roles of TEAD transcription factors and its coactivators in cancers
- (2013) Ajaybabu V. Pobbati et al. CANCER BIOLOGY & THERAPY
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
- (2013) Z. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
- (2012) Joseph Rosenbluh et al. CELL
- Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)
- (2012) J.-S. Mo et al. GENES & DEVELOPMENT
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
- (2012) B. Zhao et al. GENES & DEVELOPMENT
- Hippo signaling in mammalian stem cells
- (2012) Annie M. Tremblay et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
- (2012) Ajaybabu V. Pobbati et al. STRUCTURE
- Statins Are Associated With a Reduced Risk of Gastric Cancer: A Population-Based Case–Control Study
- (2011) Hui-Fen Chiu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
- (2011) W. Kang et al. CLINICAL CANCER RESEARCH
- Hippo signaling inDrosophila: Recent advances and insights
- (2011) Binnaz Kucuk Staley et al. DEVELOPMENTAL DYNAMICS
- RNA Interference Mediated YAP Gene Silencing Inhibits Invasion and Metastasis of Human Gastric Cancer Cell Line SGC-7901
- (2011) Zhou Zhou et al. HEPATO-GASTROENTEROLOGY
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- Structural basis of YAP recognition by TEAD4 in the Hippo pathway
- (2010) L. Chen et al. GENES & DEVELOPMENT
- Structural insights into the YAP and TEAD complex
- (2010) Z. Li et al. GENES & DEVELOPMENT
- Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions
- (2009) Chun-Li Da WORLD JOURNAL OF GASTROENTEROLOGY
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started